Mustang Bio Faces Delisting Concerns
Ticker: MBIO · Form: 8-K · Filed: Sep 13, 2024 · CIK: 1680048
Sentiment: bearish
Topics: delisting, listing-rule-violation, regulatory-filing
Related Tickers: MBIO
TL;DR
MBIO might get kicked off the exchange, big trouble brewing.
AI Summary
Mustang Bio, Inc. filed an 8-K on September 13, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing indicates potential issues with maintaining its listing on the stock exchange, with the earliest event reported as September 10, 2024.
Why It Matters
This filing signals potential financial distress or non-compliance with exchange rules, which could lead to the stock being delisted, impacting liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to trade on a major exchange, posing a significant risk to its operations and shareholder value.
Key Players & Entities
- Mustang Bio, Inc. (company) — Registrant
- September 10, 2024 (date) — Earliest event reported
- September 13, 2024 (date) — Filing date
FAQ
What specific listing rule or standard has Mustang Bio failed to satisfy?
The filing does not specify the exact rule or standard that Mustang Bio has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
What is the earliest date associated with the delisting concern?
The earliest event reported in relation to this notice is September 10, 2024.
When was this 8-K filing submitted to the SEC?
This Form 8-K was filed on September 13, 2024.
What is Mustang Bio's principal executive office address?
Mustang Bio's principal executive offices are located at 377 Plantation Street, Worcester, Massachusetts 01605.
What is Mustang Bio's telephone number?
Mustang Bio's telephone number is (781) 652-4500.
Filing Stats: 939 words · 4 min read · ~3 pages · Grade level 14.3 · Accepted 2024-09-13 16:30:51
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share MBIO Nasdaq Capital Marke
- $2.5 million — 9, 2024, to regain compliance with the $2.5 million stockholders' equity requirement for co
Filing Documents
- tm2424041d1_8k.htm (8-K) — 27KB
- 0001104659-24-099829.txt ( ) — 195KB
- mbio-20240910.xsd (EX-101.SCH) — 3KB
- mbio-20240910_lab.xml (EX-101.LAB) — 33KB
- mbio-20240910_pre.xml (EX-101.PRE) — 22KB
- tm2424041d1_8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Mustang Bio, Inc. (Registrant) Date: September 13, 2024 By: /s/ Manuel Litchman, M.D. Manuel Litchman, M.D. President and Chief Executive Officer